TianYu Bio-Technology Co., Ltd. (SHA:603717)

TianYu Bio-Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	154.66	178.05	151.6	287.73	305.66	181.46
Trading Asset Securities	-	-	10.29	-	-	-
Cash & Short-Term Investments	154.66	178.05	161.9	287.73	305.66	181.46
Cash Growth	-23.03%	9.98%	-43.73%	-5.87%	68.44%	-43.41%
Accounts Receivable	630.95	735.89	893.69	1,033	1,382	1,495
Other Receivables	175.22	167.75	307.38	294.37	296.99	229.39
Receivables	806.17	903.64	1,201	1,327	1,679	1,724
Inventory	202.9	223.77	159.63	239.74	105.95	74.45
Other Current Assets	167.59	147.34	104.87	59.85	132.42	83.03
Total Current Assets	1,331	1,453	1,627	1,914	2,223	2,063
Property, Plant & Equipment	496.06	533.56	521.79	361.86	233.26	172.62
Long-Term Investments	88	97.5	101.67	255.83	96.63	188.67
Goodwill	2.08	2.08	5.56	5.56	5	5
Other Intangible Assets	25.9	26.15	7.12	7.82	104.93	103.6
Long-Term Accounts Receivable	-	-	452.24	309.12	129.08	480.23
Long-Term Deferred Tax Assets	105.16	105.4	109.43	92.12	46.83	24.57
Long-Term Deferred Charges	4.72	4.95	5.3	4.65	3.59	18.16
Other Long-Term Assets	1,000	992.55	342.06	409.89	486.69	261.75
Total Assets	3,053	3,215	3,273	3,461	3,329	3,318
Accounts Payable	589.13	638.33	684	666.01	684.18	741.21
Accrued Expenses	28.78	27.04	19.38	16.59	6.62	7.53
Short-Term Debt	66.58	88.93	168.35	152.76	216.34	344.07
Current Portion of Long-Term Debt	-	190.1	77.61	39.39	311.02	63.04
Current Portion of Leases	-	-	25.94	33.71	6.31	79.4
Current Income Taxes Payable	-	1.13	-	1.35	2.28	2.15
Current Unearned Revenue	119.74	144.65	82.5	71.63	80.07	105.22
Other Current Liabilities	376.83	256.18	180.37	149.4	117.15	137.97
Total Current Liabilities	1,181	1,346	1,238	1,131	1,424	1,481
Long-Term Debt	781.38	753.37	751.37	649.16	212.11	460.95
Long-Term Leases	74.94	111.11	281.18	209.79	41	4
Long-Term Unearned Revenue	0.67	0.69	-	-	-	-
Long-Term Deferred Tax Liabilities	2.62	2.68	0.07	0.26	0.58	1.05
Other Long-Term Liabilities	277.07	292.25	167.5	36.79	39.59	10.51
Total Liabilities	2,318	2,506	2,438	2,027	1,717	1,957
Common Stock	290.15	290.15	290.15	290.15	290.15	241.8
Additional Paid-In Capital	912.21	912.21	931.77	931.9	930.16	585.65
Retained Earnings	-669.85	-683.62	-576.26	-81.85	197.55	412.3
Total Common Equity	532.51	518.74	645.66	1,140	1,418	1,240
Minority Interest	203.12	189.79	188.69	293.53	193.73	120.75
Shareholders' Equity	735.63	708.53	834.35	1,434	1,612	1,360
Total Liabilities & Equity	3,053	3,215	3,273	3,461	3,329	3,318
Total Debt	922.89	1,144	1,304	1,085	786.78	951.46
Net Cash (Debt)	-768.23	-965.46	-1,143	-797.09	-481.12	-770
Net Cash Per Share	-2.65	-3.33	-3.94	-3.30	-1.81	-3.18
Filing Date Shares Outstanding	289.86	289.58	290.15	290.15	290.15	241.8
Total Common Shares Outstanding	289.86	289.58	290.15	290.15	290.15	241.8
Working Capital	150.26	106.45	389.31	783.56	798.86	582.38
Book Value Per Share	1.84	1.79	2.23	3.93	4.89	5.13
Tangible Book Value	504.53	490.5	632.98	1,127	1,308	1,131
Tangible Book Value Per Share	1.74	1.69	2.18	3.88	4.51	4.68
Buildings	-	-	98.24	7.96	176.46	162.88
Machinery	-	-	209.27	88.56	31.86	34.28
Construction In Progress	-	-	19.06	7.37	3.93	1.31
Order Backlog	-	-	1,378	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.